voflan 250 mg tabletti, kalvopäällysteinen
pharmathen s.a. pharmathen s.a. - levofloxacini hemihydricum - tabletti, kalvopäällysteinen - 250 mg - levofloksasiini
voflan 500 mg tabletti, kalvopäällysteinen
pharmathen s.a. pharmathen s.a. - levofloxacini hemihydricum - tabletti, kalvopäällysteinen - 500 mg - levofloksasiini
baxogar 150 mg tabletti, kalvopäällysteinen
pharmathen pharmaceutical industry - happo ibandronicum - tabletti, kalvopäällysteinen - 150 mg - ibandronihappo
galantex 8 mg depotkapseli, kova
pharmathen s.a. pharmathen s.a. - galantamini hydrobromidum - depotkapseli, kova - 8 mg - galantamiini
galantex 16 mg depotkapseli, kova
pharmathen s.a. pharmathen s.a. - galantamini hydrobromidum - depotkapseli, kova - 16 mg - galantamiini
galantex 24 mg depotkapseli, kova
pharmathen s.a. pharmathen s.a. - galantamini hydrobromidum - depotkapseli, kova - 24 mg - galantamiini
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatiset kasvaimet - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
sildenafil teva pharma 20 mg tabletti, kalvopäällysteinen
teva pharma b.v. - sildenafili citras - tabletti, kalvopäällysteinen - 20 mg - sildenafiili
solifenacin accord 5 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - solifenacin succinate - tabletti, kalvopäällysteinen - 5 mg - solifenasiini
solifenacin accord 10 mg tabletti, kalvopäällysteinen
accord healthcare b.v. - solifenacin succinate - tabletti, kalvopäällysteinen - 10 mg - solifenasiini